WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 13'5601 Infant (under 12 months) mortality rate: 802
GDP / capita (US$): 30'2331 Child (under 5 years) mortality rate: 1182

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 736  716  696  677  658  518  374  221 
Births 26  26  26  25  25  21  18 
Surviving infants 24  24  23  23  22  18  15 
Pop. less than 5 years 113  110  107  104  101  85  69  30 
Pop. less than 15 years 288  281  274  268  262  221  141  97 
Female 15-49 years 174  169  165  161  157  119  90  44 

Number of reported case

(Click for retrospective incidence data for Equatorial Guinea)
Diphtheria
Japanese encephalitis
Measles 1'190  78  436  32 
Mumps
Pertussis 67 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever 10 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Equatorial Guinea)
Vaccine year result method % card seen                                                
BCG 2010  71  DHS     53  53  58  68  71  34 
DTP1 1999  65  MICS   41.8  54  42  59  99*  80  39 
DTP3 2010  42  DHS     41  54  44  74  74  32 
HepB_BD         
HepB3         
Hib3         
JapEnc         
MCV 2010  44  DHS     34  50  51  77  76  19 
MCV2         
PCV1         
PCV3         
Pol3 2010  34  DHS     40  53  39  68  73  32 
Rota1         
Rota_last         
Rubella1         
TT2plus 1999  52  MICS   41.8  30  64  54  57  45  30 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Equatorial Guinea)
BCG 73  73  73  73  73  73  94 
DTP1 65  65  65  65  65  65  96 
DTP3 33  33  33  33  33  33  77 
HepB3
Hib3
MCV 51  51  51  51  51  51  88 
PAB 75  75  75  75  69  61  58 
PCV3
Pol3 39  39  39  39  39  39  75 
Rota_last
YFV

Number of districts in the country 18  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
   
/
|
|
\
Greater or equal to 90% 6
From 80 to 89% 0
From 50 to 79% 11
Less than 50% 83
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 6, 10, 14 weeks; 15 months; Yes
DTwPHibHepB Yes From January 2013
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; 15 months; Yes
TT 1, 2, 6 months; 1, 2 years; Yes pregnant women
VitaminA Yes From January 2013

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  No  No  Yes 
What years does the MYP cover? number 2009-2013  2009-2013  2009-2013  2009-2013  NA    2002/2006 
Nº of districts with microplans that include activities to raise immunization coverage number 16  18   

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 18  18  18  18  18  18  18 
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 17  22  33 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100% 22  17     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR No  No  No  No    No  No 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  59  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No No  No  No  No  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.